| oGVHD | Ocular graft versus host disease |
| cGVHD | Chronic graft versus host disease |
| RE | Right eye |
| LE | Left eye |
| β2-MG | beta2-microglobulin |
| TRAIL | TNF-related apoptosis-inducing ligand |
| TRAIL-R2 | TRAIL receptor 2 |
| CCL2/MCP-1 | Chemokine ligand 2/Monocyte chemoattractant protein-1 |
| CCL3/MIP-1α | Chemokine ligand 3/Macrophage inflammatory protein 1-alpha |
| CCL4/MIP-1β | Chemokine ligand 4/Macrophage inflammatory protein 1-beta |
| CCL5/RANTES | Chemokine ligand 5/Regulated upon Activation, Normal T cell Expressed and presumably Secreted |
| CXCL5/ENA-78 | C-X-C motif chemokine 5/Epithelial cell-derived neutrophil-activating peptide |
| CXCL8/IL-8 | C-X-C motif chemokine 5/Interleukin 8 |
| FGF | Fibroblast growth factor |
| VEGF | Vascular endothelial growth factor |
| G-CSF | Granulocyte colony-stimulating factor |
| GM-CSF | Granulocyte-macrophage colony-stimulating factor |
| TNF-α | Tumor necrosis factor-alpha |
| IFN-γ | Interferon gamma |
| IL-1Ra | Interleukin-1 receptor antagonist |
| sem | Standard error of the mean |